{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T10:27:20Z","timestamp":1777372040438,"version":"3.51.4"},"reference-count":56,"publisher":"SAGE Publications","issue":"1-2","license":[{"start":{"date-parts":[[2006,8,1]],"date-time":"2006-08-01T00:00:00Z","timestamp":1154390400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Acupuncture &amp; Electro-Therapeutics Research"],"published-print":{"date-parts":[[2006,8]]},"abstract":"<jats:p>\n                    High incidences of Small Cell Carcinoma &amp; Adenocarcinoma of the lung, Astrocytoma &amp; Glioblastoma Multiforme of the brain and Mesothelioma of the lung were found in those who had a high accumulation of Asbestos in the eyes and upper respiratory system (nose, larynx, trachea, etc.). When measured non-invasively using the Bi-Digital O-Ring Test (BDORT), brain tumors had the highest concentration of Asbestos (0.2\u223c2.1 mg BDORT units). Relatively high levels of Asbestos (0.2\u223c0.6 mg BDORT units) were found in: Squamous Cell Carcinoma of the lungs &amp; esophagus, Adenocarcinoma of the larynx &amp; breast, myelogenic leukemia, arteries of these cancers, left ventricle of failing heart, myocardial infarction, some of the narrowed arteries, varicose veins, cataracts, balding heads, hot flashes, Alzheimer\u2019s Disease and Autism. A small, round or ellipsoidal area, with diameter of 5 mm or less, was found near the center of every cancer tissue with a higher level of Asbestos (1\u223c3 mg), As, Zn, Cr and Se, thanin the rest of the tumor; this small area may be where the cancer initiated. Among areas of intractable pain with frequent recurrence and gradual worsening, about 0.2-0.5 mg BDORT units (or higher) of Asbestos were found. The author found that in the Astrocytoma and many other cancer patients, the optimal dose of DHEA produced very significant reductions of cancer cell telomere from over 1400 ng in the brain tumors (and over 900 ng in other cancers) to close to or less than 1 yg (=10\n                    <jats:sup>-24<\/jats:sup>\n                    g), with circulatory improvement by reduction of TXB2. Unlike the standard, widely used treatment with DHEA 25-50 mg daily, which is an overdose; we only gave one optimal dose (1.5\u223c2.5 mg) and the beneficial effects usually lasted anywhere between 3-6 months, unless inhibiting factors were introduced. In addition, once one optimal dose of DHEA was given, the amount of Asbestos from these tumors decreased very significantly (30\u223c99% reduction) with marked increase in urine Asbestos. One optimal dose of special Cilantro tablet reduced more Asbestos than DHEA or (+) Qi Gong Energy Stored Paper. In addition, the application of (+) Solar Energy Stored Paper often reduces 70\u223c99% of the Asbestos, while (+) Qi Gong Energy Stored Paper reduces 50\u223c99% of the Asbestos.\n                  <\/jats:p>","DOI":"10.3727\/036012906815844300","type":"journal-article","created":{"date-parts":[[2015,8,10]],"date-time":"2015-08-10T20:21:38Z","timestamp":1439238098000},"page":"61-125","source":"Crossref","is-referenced-by-count":20,"title":["Asbestos As a Possible Major Cause of Malignant Lung Tumors (Including Small Cell Carcinoma, Adenocarcinoma &amp; Mesothelioma), Brain Tumors (i.e. Astrocytoma &amp; Glioblastoma Multiforme), Many Other Malignant Tumors, Intractable Pain Including Fibromyalgia, &amp; Some Cardio-Vascular Pathology: Safe &amp; Effective Methods of Reducing Asbestos From Normal &amp; Pathological Areas"],"prefix":"10.1177","volume":"31","author":[{"given":"Yoshiaki","family":"Omura","sequence":"first","affiliation":[{"name":"Director of Medical Research, Heart Disease Research Foundation"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2006,8]]},"reference":[{"key":"e_1_3_2_2_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa051185"},{"key":"e_1_3_2_3_1","doi-asserted-by":"publisher","DOI":"10.2486\/indhealth.43.346"},{"key":"e_1_3_2_4_1","doi-asserted-by":"publisher","DOI":"10.1080\/00313020400010955"},{"key":"e_1_3_2_5_1","doi-asserted-by":"publisher","DOI":"10.1136\/oem.2005.020834"},{"key":"e_1_3_2_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0169-5002(00)00231-2"},{"key":"e_1_3_2_7_1","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.20313"},{"key":"e_1_3_2_8_1","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.20820"},{"key":"e_1_3_2_9_1","doi-asserted-by":"publisher","DOI":"10.1097\/00008469-200212000-00003"},{"key":"e_1_3_2_10_1","doi-asserted-by":"publisher","DOI":"10.1309\/DEDU-V6UC-587A-9CGD"},{"key":"e_1_3_2_11_1","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/kwi285"},{"key":"e_1_3_2_12_1","doi-asserted-by":"publisher","DOI":"10.1177\/014107689008300718"},{"key":"e_1_3_2_13_1","doi-asserted-by":"publisher","DOI":"10.1289\/ehp.6704"},{"key":"e_1_3_2_14_1","doi-asserted-by":"publisher","DOI":"10.1186\/1477-7819-2-11"},{"key":"e_1_3_2_15_1","author":"Environmental Protection Agency","year":"1999","unstructured":"14.Environmental Protection Agency, \u201cAsbestos Materials Bans: Clarification, May 18, 1999\u201d, May 1999. June 21, 2006 <http:\/\/www.epa.gov\/asbestos\/pubs\/ashbans2.pdf>","journal-title":"\u201cAsbestos Materials Bans: Clarification, May 18, 1999\u201d"},{"key":"e_1_3_2_16_1","article-title":"\u201cAnalytical Method for the Determination of Asbestos in Water.\u201d","author":"Chatfield EJ","unstructured":"15.Chatfield EJ, Dillon MJ. \u201cAnalytical Method for the Determination of Asbestos in Water.\u201d Environmental Protection Agency No. 600\/4-83-043.","journal-title":"Environmental Protection Agency No. 600\/4-83-043"},{"key":"e_1_3_2_17_1","doi-asserted-by":"publisher","DOI":"10.1021\/es00117a004"},{"key":"e_1_3_2_18_1","article-title":"\u201cInterlaboralory Measurements of Amphibole and Chrysotile Fiber Concentrations in Water.\u201d","author":"Chopra KS","year":"1977","unstructured":"17.Chopra KS. \u201cInterlaboralory Measurements of Amphibole and Chrysotile Fiber Concentrations in Water.\u201d National Bureau of Standards Special Publication 506. Proceedings of the Workshop on Asbestos: Definitions and Measurement Methods, 1977.","journal-title":"Proceedings of the Workshop on Asbestos: Definitions and Measurement Methods"},{"key":"e_1_3_2_19_1","article-title":"\u201cAsbestos-Containing Materials in Schools: Final Rule and Notice.\u201d","author":"USEPA","year":"1987","unstructured":"18.USEPA, \u201cAsbestos-Containing Materials in Schools: Final Rule and Notice.\u201d Federal Register. 40 CFR Part 763. Appendix A to Subpart E, October 30, 1987.","journal-title":"Federal Register. 40 CFR Part 763"},{"key":"e_1_3_2_20_1","first-page":"1","volume-title":"Office of Research And Development U.S. Environmental Protection Agency","author":"Brackett KA","year":"1994","unstructured":"19.Brackett KA, Clark PJ, Miilette JR \u201cMethod 100.2: Determination of Asbestos Structures Over 10 \u03bcm in Length of Drinking Water.\u201d Office of Research And Development U.S. Environmental Protection Agency, pp.1-22. Cincinatti, Ohio: June 1994."},{"key":"e_1_3_2_21_1","first-page":"17","article-title":"\u201cSad Farewell to Hero EMS Ma: Kin hail 9\/11 medic who died of cancer.\u201d","author":"Martinez E","unstructured":"20.Martinez E. \u201cSad Farewell to Hero EMS Ma: Kin hail 9\/11 medic who died of cancer.\u201d New York Post, p 17, March 21, 2006","journal-title":"New York Post"},{"key":"e_1_3_2_22_1","first-page":"A1","article-title":"\u201cTracing Lung Ailments That Rose With 9\/11 Dust: Tracing Lung Ailments That Rose With the Dust of Ground Zero.\u201d","author":"DcPalma A","year":"2006","unstructured":"21.DcPalma A. \u201cTracing Lung Ailments That Rose With 9\/11 Dust: Tracing Lung Ailments That Rose With the Dust of Ground Zero.\u201d The New York Times, pp. A1 & B5. May 13, 2006.","journal-title":"The New York Times"},{"key":"e_1_3_2_23_1","first-page":"1","volume-title":"Public Citizen","author":"Public Citizen\u2019s Congress Watch","year":"2005","unstructured":"22.Public Citizen\u2019s Congress Watch. \u201cFederal Asbestos Legislation: The Winners Are\u2026\u201d Public Citizen, Washington D.C., pp. 1-44, May 2005."},{"key":"e_1_3_2_24_1","first-page":"1","volume-title":"Winnipeg Free Press","author":"Robson B","year":"1987","unstructured":"23.Robson B. \u201c Public Health Facts: Asbestos.\u201d Winnipeg Free Press, Canada, pp.1-3, February 1987."},{"key":"e_1_3_2_25_1","doi-asserted-by":"publisher","DOI":"10.3727\/036012990816358135"},{"key":"e_1_3_2_26_1","doi-asserted-by":"publisher","DOI":"10.3727\/036012992816357855"},{"key":"e_1_3_2_27_1","doi-asserted-by":"publisher","DOI":"10.3727\/036012994816357394"},{"key":"e_1_3_2_28_1","first-page":"30","volume-title":"Sawarabi Japanese Quarterly Medical Journal","author":"Omura Y","year":"1994","unstructured":"27.Omura Y, Ishida Y. \u201cSearch for the Mechanism of Bio-Sensor: When Given Medication is Ineffective what do You Suspect? How do you Identify Whether Drug is Reaching the Pathological Area to be Treated? How do You Judge the Drug-Drug Interaction? Listen to the Originator of the Bi-Digital O-Ring Test, Yoshiaki Omura.\u201d Sawarabi Japanese Quarterly Medical Journal Published by Medical Review Publishing Co., Osaka, Japan) No. 18. pp. 30-36, April 1, 1994."},{"key":"e_1_3_2_29_1","doi-asserted-by":"publisher","DOI":"10.3727\/036012995816357122"},{"key":"e_1_3_2_30_1","doi-asserted-by":"publisher","DOI":"10.3727\/036012995816357014"},{"key":"e_1_3_2_31_1","doi-asserted-by":"publisher","DOI":"10.3727\/036012996816356915"},{"key":"e_1_3_2_32_1","first-page":"50","volume-title":"\u201cMedical and Dental Problems Associated with Amalgam and the Hazards of Strong Ultraviolet Radiation used to Solidify Other Synthetic Materials as Replacements for Amalgam, and Imaging of the 4 Components of TMJ & Invisible, Hidden Pathological Findings in X-Ray Images, CT Scans, & MR1 Films, and Ultrasonic Images, Detected by the Bi-Digital O-Ring Test for Diagnosis and Treatment of Difficult Dental & MedicalProblems.\u201d","author":"Omura Y","year":"1996","unstructured":"31.Omura Y. \u201cMedical and Dental Problems Associated with Amalgam and the Hazards of Strong Ultraviolet Radiation used to Solidify Other Synthetic Materials as Replacements for Amalgam, and Imaging of the 4 Components of TMJ & Invisible, Hidden Pathological Findings in X-Ray Images, CT Scans, & MR1 Films, and Ultrasonic Images, Detected by the Bi-Digital O-Ring Test for Diagnosis and Treatment of Difficult Dental & MedicalProblems.\u201d 6th Congress of the Japan Bi-Digital O-Ring Test Medical Society, pp. 50-51, Tokyo University, Tokyo, Japan, 1996 Aug 8-10."},{"key":"e_1_3_2_33_1","first-page":"58","volume-title":"\u201cEarly Non-lnvasive Cancer Screening by Detecting Levels of Integrin a5[31. Oncogene C-fos Ab-2, Hg, Acetylcholine, Viral Infection. NO, D-Glucose, p53 (Ab-5) & Rb (Ab-8), and a New Safe and Effective Cancer Therapy Using a Mixture of EPA & DU A as an Anti-Viral Agent, & Cilantro to Remove Intracellular Mercury\u2019 and \u201cSelective Drug Uptake Enhancement Method\u201d Based on the Bi-Digital O-Ring Test Evaluation.\u201d","author":"Omura Y","year":"1998","unstructured":"32.Omura Y. \u201cEarly Non-lnvasive Cancer Screening by Detecting Levels of Integrin a5[31. Oncogene C-fos Ab-2, Hg, Acetylcholine, Viral Infection. NO, D-Glucose, p53 (Ab-5) & Rb (Ab-8), and a New Safe and Effective Cancer Therapy Using a Mixture of EPA & DU A as an Anti-Viral Agent, & Cilantro to Remove Intracellular Mercury\u2019 and \u201cSelective Drug Uptake Enhancement Method\u201d Based on the Bi-Digital O-Ring Test Evaluation.\u201d 8th Congress of the Japan Bi-Digital O-Ring Test Medical Society, pp. 58-59, Showa University. Tokyo, Japan, 1998 Jul 19-20."},{"issue":"3","key":"e_1_3_2_34_1","first-page":"225","article-title":"\u201cElectromagnetic Field Hypersensitivity, Cancer, Pre-Cancer & Abnormal Pure (-) Qi Gong Energy Emission.\u201d","volume":"23","author":"Omura Y","year":"1998","unstructured":"33.Omura Y. \u201cElectromagnetic Field Hypersensitivity, Cancer, Pre-Cancer & Abnormal Pure (-) Qi Gong Energy Emission.\u201d Acupuncture & Electro-Therapeutics Research, The International Journal, Vol. 23, No. 3 & 4, pp.225-226, 1998.","journal-title":"Acupuncture & Electro-Therapeutics Research, The International Journal,"},{"key":"e_1_3_2_35_1","first-page":"259","volume-title":"Acupuncture & Electro-Therapeutics Research, The International Journal","volume":"23","author":"Omura Y","year":"1998","unstructured":"34.Omura Y. \u201cInter-relationship Among \u201cElectromagnetic Field Hypersensitivity Syndrome\", \u201c(-) Qi Syndrome\", Pre-Cancer and Cancer: New Methods of Reversing Abnormal (-) Qi to Normal (+) Qi Energy.\u201d Presented at 14th International Symposium on Acupuncture & Electro-Therapeutics Held at Columbia University during October 22-25, 1998, Acupuncture & Electro-Therapeutics Research, The International Journal, Vol. 23, No. 3&4, pp.259-260, 1998."},{"key":"e_1_3_2_36_1","first-page":"89","volume-title":"\u201cApplication of the Bi-Digital O-Ring l est for the Localization of Accurate Organ Representation Areas at Different Parts of the Body, their Clinical Application for Diagnosis and Treatment, & their Comparison with Traditional Chinese & Ayurvedic Representation Areas, and the Effect of Acupuncture on Homocysteine, Cardiac Troponin I. and Telomere in Normal and Cancer Cells.\u201d","author":"Omura Y","year":"1999","unstructured":"35.Omura Y. \u201cApplication of the Bi-Digital O-Ring l est for the Localization of Accurate Organ Representation Areas at Different Parts of the Body, their Clinical Application for Diagnosis and Treatment, & their Comparison with Traditional Chinese & Ayurvedic Representation Areas, and the Effect of Acupuncture on Homocysteine, Cardiac Troponin I. and Telomere in Normal and Cancer Cells.\u201d Abstract of the 1st Spanish Inter-uni versitv Congress on Acupuncture (I Congreso Interuniversitario Espanol De Acupuncture), organized by 5 medical schools and the Spanish Government, published by the Faculty of Medicine, University of Zaragoza, Spain, pgs.89-91, Sept. 30-Oct. 3, 1999."},{"key":"e_1_3_2_37_1","first-page":"17","volume-title":"Abstract published in QiGong Summit 2000","author":"Omura Y","year":"2000","unstructured":"36.Omura Y. \u201cThe Application of (+) Qi Gong stored energy for the treatment of various intractable medical problems, including pain, neuromuscular problems, undesirable (-) Qi dominant state, and Electromagnetic Field Hypersensitivity (which is a frequent cause of depression, stroke, pre-Alzheimcr\u2019s disease, autism and cancer).\u201d Abstract published in QiGong Summit 2000 by the American Qigong Association and The East West Academy of Healing Arts, April 21-23, 2000, pgs. 17-18."},{"key":"e_1_3_2_38_1","first-page":"126 230","volume-title":"Acupuncture & Electro-Therapeutics Research, The International Journal","volume":"25","author":"Omura Y","year":"2000","unstructured":"37.Omura Y. \u201cAbnormal Deposits of Al, Pb, and Hg in the Brain, Particularly in the Hippocampus, as One of the Main Causes of Decreased Cerebral Acetylcholine, Electromagnetic Hypersensitivity, Pre-Alzheimer\u2019s Disease, and Autism in Children and Their New Effective Treatment by the Selective Drug Uptake Enhancement Method (Part I).\u201d Abstract published in Program & Abstracts of the 4th International Symposium on The BiDigital O-Ring Test held at Ibuka Auditorium, Wasada University in Tokyo, Japan, July 21-23, 2000, pgs. 126-127; updated article reprinted in Acupuncture & Electro-Therapeutics Research, The International Journal. Vol. 25. No. 3-4. pgs. 230-232, 2000."},{"key":"e_1_3_2_39_1","first-page":"102","volume-title":"Acupuncture & Electro-Therapeutics Research, The International Journal","volume":"26","author":"Omura Y","year":"2001","unstructured":"38.Omura Y. \u201cAbnormal Deposits of Al, Pb, and Hg in the Brain, Particularly in the Hippocampus, as one of the Main Causes of Decreased Cerebral Acetylcholine, Electromagnetic Field Hypersensitivity, Pre-Alzheimer\u2019s Disease, and Autism in Children and Their New effective Treatment by Removing These Metal Deposits Using Cilantro and the Selective Drug Uptake Enhancement Method (Part I).\u201d presented at the 4th Biennial International Symposium on the Bi-Digital O-Ring Test, July 21-23, 2001, at Waseda University, Tokyo, Acupuncture & Electro-Therapeutics Research, The International Journal. Vol. 26, No. 1-2, pgs. 102-104, 2001."},{"key":"e_1_3_2_40_1","first-page":"75 226","volume-title":"Acupuncture & Electro-Therapeutics Research, The International Journal","volume":"27","author":"Omura Y","year":"2002","unstructured":"39.Omura Y. \u201cNon-lnvasivc 6-Minute Screening of Pre-Alzheimer\u2019s Disease By Estimating Amounts of Acetylcholine, \u03b2-Amyloid (1-42), Al, Hg & Pb of the Brain, and the Safe & Effective Treatment of Prc-Alzheimer\u2019s Disease Using the \u2019Selective Drug Uptake Enhancement Method\u2019.\u201d pgs. 75-76, Abstract of 5th Biennial International Symposium on BiDigital O-Ring Test, organized and published by Japan Bi-Digital O-Ring Test Medical Society, held at Ibuka International Auditorium, Waseda University, Tokyo, Japan, during July 19-21, 2002, reprinted in Acupuncture & Electro-Therapeutics Research, The International Journal Vol. 27, 3&4,pgs.226-227, 2002."},{"key":"e_1_3_2_41_1","first-page":"84","volume-title":"\u201cQuick and Non-lnvasive Screening & Diagnosis of Cancer by Measuring Telomere, 8-OH-dG, Inlegrin a5Bl, Acetylcholine, Hg etc. and Safe & Effective Treatment of Cancer: Marked Decrease of the Telomere of Cancer Cell & Increase of the Normal Cell Telomere by Stimulating the Press Needle Inserted at True St. 36 and Effective Treatment & Longevity Effect of Selective Drug Uptake Enhancement Method.\u201d","author":"Omura Y","year":"2004","unstructured":"40.Omura Y. \u201cQuick and Non-lnvasive Screening & Diagnosis of Cancer by Measuring Telomere, 8-OH-dG, Inlegrin a5Bl, Acetylcholine, Hg etc. and Safe & Effective Treatment of Cancer: Marked Decrease of the Telomere of Cancer Cell & Increase of the Normal Cell Telomere by Stimulating the Press Needle Inserted at True St. 36 and Effective Treatment & Longevity Effect of Selective Drug Uptake Enhancement Method.\u201d Program & Abstracts of 6th Biennial International Symposium on the Bi-Digital O-Ring Test. Pgs 84-88, held at Waseda University, Tokyo, Japan, August 6-8, 2004 (Summary of 45 minute presentation as the main guest speaker.)"},{"key":"e_1_3_2_42_1","first-page":"47","volume-title":"\u201cNon-lnvasive Quick Screening of Cancer, Cardio-Vascular Disease, Alzheimer\u2019s Disease and Cause of Intractable pain and Their Accurate Localization Using X-, Y-Axis Laser Line Scanning of the Whole Body & New, Safe and Effective Treatments with the Selective Drug Uptake Enhancement Method.\u201d","volume":"2","author":"Omura Y","year":"2004","unstructured":"41.Omura Y. \u201cNon-lnvasive Quick Screening of Cancer, Cardio-Vascular Disease, Alzheimer\u2019s Disease and Cause of Intractable pain and Their Accurate Localization Using X-, Y-Axis Laser Line Scanning of the Whole Body & New, Safe and Effective Treatments with the Selective Drug Uptake Enhancement Method.\u201d in book Science of Whole Person I lealing: Proceedings of the First Interdisciplinary International Conference, Volume 2, edited by Roy Rustum, pgs 47-96 of 418 pg book published in 2004 by iUnivcrsc, Inc.. New York, Lincoln, Shanghai. Original meeting was held in Bethesda, MD, March 28-30, 2003."},{"key":"e_1_3_2_43_1","first-page":"65","volume-title":"Management of Pain: A World Perspective","author":"Omura Y","year":"2000","unstructured":"42.Omura Y. \u201cNon-lnvasivc Diagnosis & Effective Treatment of Chronic Intractable Lower Back Pain Using the Bi-Digital O-Ring Test Resonance Phenomenon & The Selective Drug Uptake Enhancement Method.\u201d pp. 65-74, in the hardcover book Management of Pain: A World Perspective, ed. Yanagida H, Hanaoka K, Yuge O, published as part of the 9th International Symposium on Pain, organized by the International Association for the Study of Pain, by Monduzzi Editore, Bologna, Italy, 2000."},{"key":"e_1_3_2_44_1","first-page":"150","article-title":"\u201cMajor Causes of Electromagnetic Field Hypersensitivity, Strong (-) Qi, PreAlzheimer\u2019s & Alzheimer\u2019s Disease, Autism & Abnormal Mental or Motor Function, & Cancer; Their Effective Treatment Using The Selective Drug Uptake Enhancement Method with (+) Qi Gong Energy-Stored paper, and Normal Cell Telomere-Increasing Effect & Cancer Cell Telomere-Decreasing Effect of (+) Qi Gong Energy-Stored Paper on True St. 36\u201d","author":"Omura Y","year":"2001","unstructured":"43.Omura Y. \u201cMajor Causes of Electromagnetic Field Hypersensitivity, Strong (-) Qi, PreAlzheimer\u2019s & Alzheimer\u2019s Disease, Autism & Abnormal Mental or Motor Function, & Cancer; Their Effective Treatment Using The Selective Drug Uptake Enhancement Method with (+) Qi Gong Energy-Stored paper, and Normal Cell Telomere-Increasing Effect & Cancer Cell Telomere-Decreasing Effect of (+) Qi Gong Energy-Stored Paper on True St. 36\u201d, Summary of one hour lecture presented at the International Symposium on Bridging Worlds and Filling Gaps in the Science of Healing, held November 29-December 3, 2001 at Kona, organized by Dr. Wayne Jonas of the Samucli Institute, who is the former Director of the Alternative Medicine section of N.I.H., Dr. Marilyn Schlitz of Noetic Sciences and Dr.Mitchcll W. Krucoff of Duke University. Published in the 482 page book Proceedings: Bridging Worlds and Filling Gaps in the Science of Healing (Edited by Chez RonaldA), Noetic Science, pgs. 150-176, April, 2002.","journal-title":"Proceedings: Bridging Worlds and Filling Gaps in the Science of Healing"},{"key":"e_1_3_2_45_1","doi-asserted-by":"publisher","DOI":"10.3727\/036012905815901226"},{"issue":"1","key":"e_1_3_2_46_1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3727\/036012904815901551","article-title":"\u201cSpecial Sunrise & Sunset Solar Energy Stored Papers and Their Clinical Applications for Intractable Pain, Circulatory Disturbances & Cancer: Comparison of Beneficial Effects Between Special Solar Energy Stored Paper and Qigong Energy Stored Paper.\u201d","volume":"29","author":"Omura Y","year":"2004","unstructured":"45.Omura Y. \u201cSpecial Sunrise & Sunset Solar Energy Stored Papers and Their Clinical Applications for Intractable Pain, Circulatory Disturbances & Cancer: Comparison of Beneficial Effects Between Special Solar Energy Stored Paper and Qigong Energy Stored Paper.\u201d Acupuncture & Electro-Therapeutics Research, The International Journal. Volume 29, Number 1\/2, pgs. 1-42, 2004.","journal-title":"Acupuncture & Electro-Therapeutics Research, The International Journal."},{"key":"e_1_3_2_47_1","doi-asserted-by":"publisher","DOI":"10.2307\/4017077"},{"key":"e_1_3_2_48_1","author":"OM Group","year":"2006","unstructured":"47.OM Group. \u201cFuel Oil Additives\u201d, July 8, 2006, <http:\/\/www.omgi.com\/buprod\/metal_organics\/productshomogeneous_catalysts\/default.asp>","journal-title":"\u201cFuel Oil Additives\u201d"},{"key":"e_1_3_2_49_1","volume-title":"U.S. Public Health Service, U.S. Department of Health and I himan Services","author":"Agency for Toxic Substances and Disease Registry (ATSDR)","year":"1998","unstructured":"48.Agency for Toxic Substances and Disease Registry (ATSDR). \u201cToxicological Profile for Chromium.\u201d U.S. Public Health Service, U.S. Department of Health and I himan Services. Atlanta, GA, 1998."},{"key":"e_1_3_2_50_1","volume-title":"National Center for Environmental Assessment. Office of Research and Development.","author":"U.S. Environmental Protection Agency","year":"1998","unstructured":"49.U.S. Environmental Protection Agency. \u201c Toxicological Review of Trivalent Chromium.\u201d National Center for Environmental Assessment. Office of Research and Development. Washington, D.C.. 1998."},{"key":"e_1_3_2_51_1","volume-title":"National Center for Environmental Assessment, Office of Research and Development","author":"U.S. Environmental Protection Agency","year":"1998","unstructured":"50.U.S. Environmental Protection Agency. \u201cToxicological Review of Hexavalcnt Chromium.\u201d National Center for Environmental Assessment, Office of Research and Development. Washington, D.C., 1998."},{"key":"e_1_3_2_52_1","volume-title":"\u201cEnvironmental Health Criteria 61.\u201d","author":"World Health Organization","year":"1988","unstructured":"51.World Health Organization. Chromium. \u201cEnvironmental Health Criteria 61.\u201d Geneva, Switzerland, 1988."},{"key":"e_1_3_2_53_1","volume-title":"National Center for Environmental Assessment. Office of Research and Development","author":"U.S. Environmental Protection Agency","year":"1999","unstructured":"52.U.S. Environmental Protection Agency, \u201cIntegrated Risk Information System (IRIS) on Chromium VL\u201d National Center for Environmental Assessment. Office of Research and Development. Washington, D.C., 1999."},{"key":"e_1_3_2_54_1","article-title":"\u201cCode of Federal Regulations.\u201d","author":"Occupational Safety and Health Administration (OSHA)","year":"1998","unstructured":"53.Occupational Safety and Health Administration (OSHA). \u201cCode of Federal Regulations.\u201d Occupational Safety and Health Standards, Toxic and Hazardous Substances. 29 CFR 1910.1000, 1998.","journal-title":"Occupational Safety and Health Standards, Toxic and Hazardous Substances. 29 CFR 1910.1000"},{"key":"e_1_3_2_55_1","volume-title":"U.S. Department of Health and Human Services, Public Health Service, Centers for Disease Control and Prevention","author":"National Institute for Occupational Safely and Health (NIOSH)","year":"1997","unstructured":"54.National Institute for Occupational Safely and Health (NIOSH). \u201cPocket Guide to Chemical Hazards.\u201d U.S. Department of Health and Human Services, Public Health Service, Centers for Disease Control and Prevention. Cincinnati, OH, 1997."},{"key":"e_1_3_2_56_1","author":"Environmental Protection Agency","year":"2000","unstructured":"55.Environmental Protection Agency, \u201cChromium Compounds: Hazard Summary -Created in April 1992; Revised in January 2000\u201d, January 2000. June 21, 2006 <http:\/\/www.epa.gov\/rtn\/atw\/hlthef\/chromium.htm>","journal-title":"\u201cChromium Compounds: Hazard Summary -Created in April 1992; Revised in January 2000\u201d"},{"key":"e_1_3_2_57_1","doi-asserted-by":"publisher","DOI":"10.1080\/00984100290071018"}],"container-title":["Acupuncture &amp; Electro-Therapeutics Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.3727\/036012906815844300","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.3727\/036012906815844300","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.3727\/036012906815844300","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T08:52:14Z","timestamp":1777366334000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.3727\/036012906815844300"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,8]]},"references-count":56,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2006,8]]}},"alternative-id":["10.3727\/036012906815844300"],"URL":"https:\/\/doi.org\/10.3727\/036012906815844300","relation":{},"ISSN":["0360-1293","2167-9010"],"issn-type":[{"value":"0360-1293","type":"print"},{"value":"2167-9010","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,8]]}}}